Answer Choices:
Who is menstruating.
🩸Menstruation is not a contraindication for fibrinolytic therapy in clients with myocardial infarction.
🚫Uncontrolled hypertension and a history of cerebral aneurysm increase the risk of life-threatening hemorrhage, making them contraindications.
💊Clients on warfarin already have an altered coagulation state, increasing the risk of bleeding with fibrinolytics.
🧠The client who is menstruating remains a safe candidate for this therapy despite the presence of mild bleeding.
📌Core Message
Fibrinolytics are safe in menstruating clients but contraindicated in high bleeding-risk conditions.
This question is from NCLEX RN-Readiness Assessment Test-3 which contains 38 questions.
Answer Choices:
Answer Choices:
Answer Choices:
Answer Choices:
Answer Choices: